SGS is now offering clients large molecule bioanalytical services at its laboratory in Wavre, Belgium.
Geneva, December 7, 2017: SGS, a leading bio/pharmaceutical analytical and bioanalytical contract solutions provider, is now offering clients large molecule bioanalytical services at its laboratory in Wavre, Belgium. The facility has invested in new and dedicated LC/MS-MS instruments and is currently validating internal methods within the laboratory, ensuring that services will be available by the end of 2017.
The investment includes the installation of Sciex instruments, and the introduction of supporting Sciex BioBA sample preparation kits. This will allow the laboratory to handle the analysis of a wide range of samples, including peptides, proteins and complex biological molecules, such as monoclonal antibodies. Initially, the service will focus on pre-clinical samples, with the aim of rapidly expanding this to analytical methods used for clinical studies.
Bernard Jeanbaptiste, Bioanalysis Manager for SGS Belgium, said: “Our laboratory at Wavre has a rich history and expertise in small molecule analysis and the use of LC/MS-MS techniques. As a result, this investment is a natural progression of our capabilities, enabling us to serve the growing market for large molecule analysis and characterization. The investment will bring value to clients and support our current activities in large molecule bioanalysis across the global SGS network.”
SGS’s Wavre 8,400 sq m laboratory, on the outskirts of Brussels, provides a wide range of services to clients around the world, including method development and validation, analytical chemistry, microbiological testing, potency assays and cell line characterization.
With 20 laboratories offering contract analytical and bioanalytical services, SGS leverages its wholly-owned global network, present in North America, Europe, and Asia, to deliver harmonized solutions to large pharmaceutical and biotechnology firms. In addition to testing services for the bio/pharmaceutical market, SGS also provides Phase I-IV clinical trial management, and services encompassing data management and statistics, PK/PD modeling and simulation, pharmacovigilance and regulatory consultancy.
In Europe, the integrated SGS laboratory network contains several specialist service centers providing support for the testing requirements associated with small and large molecule development, including characterization of large molecules and bioanalysis.
About SGS
SGS is the world’s leading inspection, verification, testing and certification company. SGS is recognized as the global benchmark for quality and integrity. With more than 90,000 employees, SGS operates a network of over 2,000 offices and laboratories around the world.
